Resources

Selected
  • 国电电力 2025年光伏毛利率
Type of publications
Regions
Diseases
273 results found
2025 ∙ Wang, Y. Zhang, Y. Wang, J. Shi, N. Jin, H.
Enhancing influenza vaccination uptake: a systematic review and meta-analysis of intervention strategies
All age groups Pregnant women Healthcare workers Influenza Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Liu, J. Zhang, Y. Zhang, H. Tan, H.
Estimating the effects of interventions on increasing vaccination: systematic review and meta-analysis
All age groups Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Szondy, I. Lorincz, K. Walter, A. Mohammed, A. A. Hegyi, P. Kiss, N. Meznerics, F. A. Banvolgyi, A.
Evaluating cross-protection: Meningococcal vaccines show effectiveness in gonorrhoea prevention - A systematic review and meta-analysis
All age groups Meningococcal disease Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Jotautis, V. Sarantaki, A.
Evaluating the Efficacy and Safety of Hepatitis E Vaccination in Reproductive-Age Women: A Systematic Review and Meta-Analysis
Adolescents Adults Hepatitis E Efficacy/effectiveness Safety
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Alandijany, T. A. Qashqari, F. S.
Evaluating the efficacy, safety, and immunogenicity of FDA-approved RSV vaccines: a systematic review of Arexvy, Abrysvo, and mResvia
All age groups Pregnant women RSV (Respiratory syncytial virus) Efficacy/effectiveness Safety Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Siddiqui, E. Khan, M. S. Khalid, M. Chandani, H. K. Naeem, U. Khan, M. M. Wasti, S. O.
Evaluating the immunogenicity and safety of ID93 + GLA-SE in BCG-vaccinated healthy adults: a systematic review and meta-analysis of randomized controlled trials
Adults Tuberculosis Efficacy/effectiveness Safety
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Williams, L. R. Hombach, J. Marti, M.
Evaluating the Immunogenicity, Efficacy, and Effectiveness of Recombinant Zoster Vaccine for Global Public Health Policy
All age groups Herpes zoster Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Sterian, M. Naganathan, T. Corrin, T. Waddell, L.
Evidence on the associations and safety of COVID-19 vaccination and post COVID-19 condition: An updated living systematic review
All age groups COVID-19 Efficacy/effectiveness Safety Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Heinze, N. Martin, A. F. Tirion, A. S. C. Pae, R. Islam, J. Smith, L. E. Weston, D. Rubin, G. J.
Exploring the effectiveness of interventions to increase uptake of measles vaccination among healthcare workers: a systematic review
Healthcare workers Adolescents Adults Older adults Measles Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Abbasi, T. N. Khan, M. S. Siddiqui, E. Zaheer, M. A. Tabassum, A. Zainab, N. Waafira, A.
Exploring the safety and immunogenicity of the VLA15 vaccine among healthy or high-risk population: a systematic review and meta-analysis of randomized controlled trials
All age groups Lyme disease, Borreliosis Efficacy/effectiveness Safety Administration
Methodological quality (AMSTAR 2):
Critically low
Loading...